IL‐17 Affects the Progression, Metastasis, and Recurrence of Laryngeal Cancer <i>via</i> the Inhibition of Apoptosis through Activation of the PI3K/AKT/FAS/FASL Pathways

Abstract

In summary, these findings demonstrated for the first time the role of IL-17 as a tumor promoter and a prometastatic factor in LC and indicated that IL-17 may have an oncogenic role and serve as a potential prognostic biomarker and therapeutic target in LC.